Company research
TG THERAPEUTICS, INC.
CIK 1001316Updated Sep 24, 2026
SecurityTGTX · NASDAQ · equity
Name history
MANHATTAN PHARMACEUTICALS INC · through Apr 27, 2012ATLANTIC TECHNOLOGY VENTURES INC · through Mar 10, 2003ATLANTIC PHARMACEUTICALS INC · through Feb 4, 2000
TGTX price & chart
Loading TradingView…
NASDAQ:TGTX on TradingView ↗In the news
Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm ↗
Recent filings
Show 5 more recent filings
4 filing
Submission of Matters to a Vote of Security Holders
Items 5.07
Other Events
Items 8.01, 9.01
Other Events
Items 8.01, 9.01
10-Q filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,063,253,000Source | 577,690,000Source | 329,587,000Source | 193,572,000Source |
| Property, Plant and Equipment, NetUSD | — | — | 95,000Source | 307,000Source |
| GoodwillUSD | — | — | 799,000Source | 799,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 79,148,000Source | 179,894,000Source | 92,933,000Source | 102,304,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 305,628,000Source | 129,185,000Source | 51,093,000Source | — |
| Inventory, NetUSD | 125,586,000Source | 110,458,000Source | 39,823,000Source | — |
| Assets, CurrentUSD | 630,764,000Source | 566,359,000Source | 317,943,000Source | 168,274,000Source |
| Operating Lease, Right-of-Use AssetUSD | 6,278,000Source | 7,151,000Source | 8,050,000Source | 8,888,000Source |
| Other Assets, NoncurrentUSD | 2,044,000Source | 2,074,000Source | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 415,233,000Source | 355,326,000Source | 169,085,000Source | 134,985,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 159,000Source | 156,000Source | 151,000Source | 146,000Source |
| Additional Paid in CapitalUSD | 1,830,110,000Source | 1,760,396,000Source | 1,674,946,000Source | 1,585,708,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,082,015,000Source | -1,529,194,000Source | -1,514,361,000Source | -1,527,033,000Source |
| Stockholders' Equity Attributable to ParentUSD | 648,020,000Source | 222,364,000Source | 160,502,000Source | — |
| Liabilities and EquityUSD | 1,063,253,000Source | 577,690,000Source | 329,587,000Source | 193,572,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 153,760,000Source | 90,679,000Source | 53,720,000Source | 53,201,000Source |
| Operating Lease, Liability, CurrentUSD | 1,044,000Source | 1,157,000Source | 1,446,000Source | 1,581,000Source |
| Operating Lease, Liability, NoncurrentUSD | 7,021,000Source | 8,133,000Source | 9,231,000Source | 10,344,000Source |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 199,500,000Source | 311,000,000Source | 217,500,000Source | 174,100,000Source |
| Deferred Revenue, CurrentUSD | 21,234,000Source | 11,414,000Source | — | — |
| Deferred Revenue, NoncurrentUSD | 8,807,000Source | 12,085,000Source | 6,016,000Source | 305,000Source |
| Long-term Debt, Current MaturitiesUSD | — | — | — | 0Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 245,645,000Source | 244,429,000Source | 100,118,000Source | 71,135,000Source |
| Short-term InvestmentsUSD | 62,822,000Source | 131,106,000Source | 124,575,000Source | 59,374,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -198,335,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 59,000Source | 68,000Source | 211,000Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 64,670,000Source | 42,541,000Source | 37,933,000Source | 19,185,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 176,443,000Source | 78,092,000Source | 51,093,000Source | -1,389,000Source |
| Increase (Decrease) in InventoriesUSD | 33,452,000Source | 66,851,000Source | 36,938,000Source | — |
| Deferred Income Tax Expense (Benefit)USD | -348,000,000Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -24,772,000Source | -40,517,000Source | -31,413,000Source | -176,170,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 13,799,000Source | -1,036,000Source | -50,651,000Source | -20,013,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 214,000Source | 45,000Source | 0Source | 14,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -89,729,000Source | 128,527,000Source | 72,705,000Source | -391,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -100,702,000Source | 86,974,000Source | -9,359,000Source | -196,574,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 80,490,000Source | 181,192,000Source | 94,218,000Source | 103,577,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 24,249,000Source | 18,470,000Source | 8,771,000Source | 5,445,000Source |
| Income Taxes Paid, NetUSD | 7,879,000Source | 500,000Source | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 64,700,000Source | 42,500,000Source | 37,900,000Source | — |
| Amortization of Debt Issuance CostsUSD | 1,216,000Source | 1,995,000Source | 2,378,000Source | 1,844,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 1,200,000Source | — | — | — |
| Amortization of Intangible AssetsUSD | — | — | — | 212,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 199,500,000Source | 311,000,000Source | 217,500,000Source | 174,100,000Source |
| DepreciationUSD | — | — | — | 303,000Source |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | -298,000Source | -754,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | -4,607,000Source | — | — |
| GoodwillUSD | — | — | 799,000Source | 799,000Source |
| Goodwill, Impairment LossUSD | — | — | — | 0Source |
| Income Tax Expense (Benefit)USD | -339,789,000Source | 2,211,000Source | 390,000Source | 0Source |
| InterestExpenseNonoperatingUSD | 26,727,000Source | 24,028,000Source | — | — |
| Inventory Write-downUSD | 6,171,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | 447,179,000Source | 23,383,000Source | 12,672,000Source | — |
| Nonoperating Income (Expense)USD | -15,934,000Source | -16,335,000Source | -7,571,000Source | -5,496,000Source |
| Operating ExpensesUSD | — | — | — | 195,624,000Source |
| Operating Lease, ExpenseUSD | — | — | 2,200,000Source | 2,700,000Source |
| Other Nonoperating Income (Expense)USD | 10,793,000Source | 7,693,000Source | 5,044,000Source | — |
| Payments of Financing CostsUSD | 0Source | 889,000Source | 125,000Source | — |
| Proceeds from Issuance of Common StockUSD | 0Source | — | 46,296,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 1,511,000Source | 914,000Source | 1,534,000Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 616,287,000Source | 329,004,000Source | 233,662,000Source | 2,785,000Source |
| Cost of RevenueUSD | 100,714,000Source | 38,486,000Source | 14,131,000Source | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 232,034,000Source | 154,298,000Source | 122,706,000Source | 70,007,000Source |
| Operating Income (Loss)USD | 123,324,000Source | 41,929,000Source | 20,633,000Source | -192,839,000Source |
| Other Nonoperating Income (Expense)USD | 10,793,000Source | 7,693,000Source | 5,044,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 107,390,000Source | 25,594,000Source | 13,062,000Source | -198,335,000Source |
| Income Tax Expense (Benefit)USD | -339,789,000Source | 2,211,000Source | 390,000Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | 447,179,000Source | 23,383,000Source | 12,672,000Source | — |
| Earnings Per Share, BasicUSD per share | 3.1Source | 0.16Source | 0.09Source | -1.46Source |
| Earnings Per Share, DilutedUSD per share | 2.77Source | 0.15Source | 0.09Source | -1.46Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 144,316,786Source | 145,317,418Source | 141,955,112Source | 135,411,258Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 161,412,746Source | 160,336,051Source | 148,508,465Source | 135,411,258Source |
| Interest Expense (non-operating)USD | 26,727,000Source | 24,028,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | — | — | 212,000Source |
| Costs and ExpensesUSD | 492,963,000Source | 287,075,000Source | 213,029,000Source | — |
| Current Income Tax Expense (Benefit)USD | 8,211,000Source | — | 400,000Source | — |
| Goodwill, Impairment LossUSD | — | — | — | 0Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 107,739,000Source | — | — | — |
| Interest ExpenseUSD | — | — | 12,615,000Source | 10,191,000Source |
| Nonoperating Income (Expense)USD | -15,934,000Source | -16,335,000Source | -7,571,000Source | -5,496,000Source |
| Operating ExpensesUSD | — | — | — | 195,624,000Source |
| Operating Lease, ExpenseUSD | — | — | 2,200,000Source | 2,700,000Source |
| Other IncomeUSD | — | — | — | 4,695,000Source |
| Research and Development ExpenseUSD | 160,215,000Source | 94,291,000Source | 76,192,000Source | 125,352,000Source |